 DARTMOUTH, Nova Scotia--BUSINESS WIRE--- IMV DeliveryPlatform--IMV Inc. IMV or the Corporation Nasdaq: IMV; TSX: IMV, a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, announced today that it will hold a conference call and webcast on Wednesday, August 11, 2021 at 8:00 a.m. ET to discuss the companys second quarter 2021 financial and operational results. Financial analysts are invited to join the conference call by dialing 866 211-32 